CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Report for D009181: Mycoses NIH

(Synonyms: Mycoses)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (0)

Name (Synonyms) Correlation

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU

Characterization of fungal infections in COVID-19 infected and mechanically ventilated patients in ICU

NCT04368221 Covid-19
MeSH:Mycoses

Primary Outcomes

Description: Prevalence of opportunistic fungal co-infections.

Measure: Opportunistic fungal co-infections.

Time: at 12 months

Secondary Outcomes

Description: Determination of the median time between entry in ICU and beginning of ARDS and (i) colonization and (ii) probable/proven infection with Aspergillus, Pneumocystis jirovecii and mucormycetes

Measure: Median time

Time: at 12 months

Description: Evaluation of the time between diagnosis and targeted treatment

Measure: Time between diagnosis and targeted treatment

Time: at ICU discharge, up to 1 month

Description: Number of proposals for evaluation of preventive strategies if necessary, because of high incidence, in terms of chemoprophylaxis and/or environmental measures

Measure: Preventive strategies

Time: At 12 months

HPO Nodes